SamJonesCoxIIIMD

PubMed

• Disposition of firocoxib in late pregnant and early postpartum mares.
  Giguère S, Macpherson ML, Benson SM, Cox S, McNaughten JW, Pozor MA> ;J. Vet. Pharmacol. Ther.. 2016-04-01
• Comparative plasma pharmacokinetics of ceftiofur sodium and ceftiofur crystalline-free acid in neonatal calves.
  Woodrow, J. S.,Caldwell, M.,Cox, S.,Hines, M.,Credille, B. C.> ;J. Vet. Pharmacol. Ther.. 2015 Nov 07
• Pharmacokinetics of intravenous and subcutaneous cefovecin in alpacas.
  Cox, S.,Sommardahl, C.,Seddighi, R.,Videla, R.,Hayes, J.,Pistole, N.,Hamill, M.,Doherty, T.> ;J. Vet. Pharmacol. Ther.. 2014 Nov 20
• Disposition of firocoxib in equine plasma after an oral loading dose and a multiple dose regimen.
  Cox, S.,Villarino, N.,Sommardahl, C.,Kvaternick, V.,Zarabadipour, C.,Siger, L.,Yarbrough, J.,Amicucci, A.,Reed, K.,Breeding, D.,Doherty, T.> ;Vet. J.. 2013 Sep 4
• Pulmonary pharmacokinetics of tulathromycin in swine. Part I: Lung homogenate in healthy pigs and pigs challenged intratracheally with lipopolysaccharide of Escherichi...
  Villarino, N.,Lesman, S.,Fielder, A.,García-Tapia, D.,Cox, S.,Lucas, M.,Robinson, J.,Brown, S. A.,Martín-Jiménez, T.> ;J. Vet. Pharmacol. Ther.. 2013 Aug
• Pulmonary pharmacokinetics of tulathromycin in swine. Part 2: Intra-airways compartments.
  Villarino, N.,Lesman, S.,Fielder, A.,García-Tapia, D.,Cox, S.,Lucas, M.,Robinson, J.,Brown, S. A.,Martín-Jiménez, T.> ;J. Vet. Pharmacol. Ther.. 2013 Aug
• Pharmacokinetics of a single oral dose of acyclovir and valacyclovir in North American box turtles (Terrapene sp.).
  Allender MC, Mitchell MA, Yarborough J, Cox S> ;J. Vet. Pharmacol. Ther.. 2013-04-01
• Pharmacokinetics of firocoxib and its interaction with enrofloxacin in horses.
  Cox, S.,Dudenbostel, L.,Sommardahl, C.,Yarbrough, J.,Saleh, M.,Doherty, T.> ;J. Vet. Pharmacol. Ther.. 2012 Jan 12
• Pharmacokinetics of lidocaine after intravenous administration to cows.
  Cox, S.,Wilson, J.,Doherty, T.> ;J. Vet. Pharmacol. Ther.. 2011 Aug 13
• A DNA vaccination regime including protein boost and electroporation protects cattle against foot-and-mouth disease.
  Fowler V, Robinson L, Bankowski B, Cox S, Parida S, Lawlor C, Gibson D, O'Brien F, Ellefsen B, Hannaman D, Takamatsu H, Barnett PV> ;Antiviral Res.. 2012-04-01
• Foot-and-mouth disease marker vaccine: cattle protection with a partial VP1 G-H loop deleted virus antigen.
  Fowler VL, Bashiruddin JB, Maree FF, Mutowembwa P, Bankowski B, Gibson D, Cox S, Knowles N, Barnett PV> ;Vaccine. 2011-10-26
• Pharmacokinetics of intravenous and intramuscular tramadol in llamas.
  Cox, S.,Martin-Jimenez, T.,van Amstel, S.,Doherty, T.> ;J. Vet. Pharmacol. Ther.. 2011 Apr 16
• Determination of firocoxib in equine plasma using high performance liquid chromatography.
  Cox, S.,Yarbrough, J.> ;J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.. 2010 Dec 28
• Determination of oral tramadol pharmacokinetics in horses.
  Cox, S.,Villarino, N.,Doherty, T.> ;Res. Vet. Sci.. 2010 Mar 13
• Pharmacokinetics of intravascular itraconazole in the American horseshoe crab (Limulus polyphemus).
  Allender MC, Schumacher J, Milam J, George R, Cox S, Martín-Jiménez T> ;J. Vet. Pharmacol. Ther.. 2008-02-01
• Evaluation of a monoclonal antibody-based approach for the selection of foot-and-mouth disease (FMD) vaccine strains.
  Mahapatra M, Aggarwal N, Cox S, Statham RJ, Knowles NJ, Barnett PV, Paton DJ> ;Vet. Microbiol.. 2008-01-01
• Porcine gammadelta T cells: possible roles on the innate and adaptive immune responses following virus infection.
  Takamatsu H, Denyer MS, Stirling C, Cox S, Aggarwal N, Dash P, Wileman TE, Barnett PV> ;Vet. Immunol. Immunopathol.. 2006-07-15
• Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle.
  Cox SJ, Voyce C, Parida S, Reid SM, Hamblin PA, Hutchings G, Paton DJ, Barnett PV> ;Vaccine. 2006-04-12
• Interferon-gamma production in vitro from whole blood of foot-and-mouth disease virus (FMDV) vaccinated and infected cattle after incubation with inactivated FMDV.
  Parida S, Oh Y, Reid SM, Cox SJ, Statham RJ, Mahapatra M, Anderson J, Barnett PV, Charleston B, Paton DJ> ;Vaccine. 2006-02-13
• The application of new techniques to the improved detection of persistently infected cattle after vaccination and contact exposure to foot-and-mouth disease.
  Parida S, Cox SJ, Reid SM, Hamblin P, Barnett PV, Inoue T, Anderson J, Paton DJ> ;Vaccine. 2005-10-25
• Detection of antibody to the foot-and-mouth disease virus (FMDV) non-structural polyprotein 3ABC in sheep by ELISA.
  Armstrong RM, Cox SJ, Aggarwal N, Mackay DJ, Davies PR, Hamblin PA, Dani P, Barnett PV, Paton DJ> ;J. Virol. Methods. 2005-05-01
• Protection against direct-contact challenge following emergency FMD vaccination of cattle and the effect on virus excretion from the oropharynx.
  Cox SJ, Voyce C, Parida S, Reid SM, Hamblin PA, Paton DJ, Barnett PV> ;Vaccine. 2005-01-19
• Evidence that high potency foot-and-mouth disease vaccine inhibits local virus replication and prevents the "carrier" state in sheep.
  Barnett PV, Keel P, Reid S, Armstrong RM, Statham RJ, Voyce C, Aggarwal N, Cox SJ> ;Vaccine. 2004-03-12
• Longevity of antibody and cytokine responses following vaccination with high potency emergency FMD vaccines.
  Cox SJ, Aggarwal N, Statham RJ, Barnett PV> ;Vaccine. 2003-03-28
• Further studies on the early protective responses of pigs following immunisation with high potency foot and mouth disease vaccine.
  Barnett PV, Cox SJ, Aggarwal N, Gerber H, McCullough KC> ;Vaccine. 2002-08-19
• Join now to see all